Assessment of Tumor Infiltrating Lymphocytes in Predicting Stereotactic Ablative Radiotherapy (SABR) Response in Unresectable Breast Cancer

Background: Patients with advanced breast cancer (BC) may be treated with stereotactic ablative radiotherapy (SABR) for tumor control. Variable treatment responses are a clinical challenge and there is a need to predict tumor radiosensitivity a priori. There is evidence showing that tumor infiltrati...

Full description

Saved in:
Bibliographic Details
Main Authors: Mateusz Bielecki, Khadijeh Saednia, Fang-I Lu, Shely Kagan, Danny Vesprini, Katarzyna J. Jerzak, Roberto Salgado, Raffi Karshafian, William T. Tran
Format: Article
Language:English
Published: MDPI AG 2025-04-01
Series:Radiation
Subjects:
Online Access:https://www.mdpi.com/2673-592X/5/2/11
Tags: Add Tag
No Tags, Be the first to tag this record!